TRADING Vs INVESTING - PART 2 - ZOMATO IPO SPECIALFor the purposes of writing this series, I have assumed that the reader is not having a large capital base as, given the current scenario, an average person would find it hard to release funds that can be used for trading / Investing.
Tax definition of Trading & Investing
In a very simple manner, the key difference between Trading and Investing can be explained in the following manner ---
Trading gains would be considered as business income for a trader or as a short-term capital gain for an investor attracting the applicable income tax rate.
Investing gains would be considered as long-term capital gains attracting a lower rate of income tax.
So if I invest in 100 Shares of Reliance at 2100 and sell it within 10 days at 2300, I would end up making a short-term capital gain of 100*200 = 20,000 if trading is not my business income. And I would end up making a taxable income of 20,000 if trading was part of my business income.
Now, if I sell the shares bought above after 367 days at 1950, I would end up incurring a business loss of 100*150 = 15,000 if trading was part of my business income. However, I would end up incurring 15,000 as a long-term capital loss if I was not a trader and trading was not part of my business income or I was a salaried person.
Why look at IPOs?
Historically, IPOs have attracted lots of retailers as on many occasions, they have offered bumper listing gains and the retailers would generally seek quick and riskless gains from the investments made.Logically, the words “ quick and riskless” do not go hand in hand and certainly not with an “investment”. The reason being that investments tend to be for a longer period of time than other means of savings or money-making.
In my view, for a retail person, with limited means to risk their precious capital, IPOs generally offer a good way to start the Investment journey. SEBI has made IPO investments an affordable process for the retail category as the lot size or the minimum amount that one can invest is around 15,000. One can always apply for multiple lots but if I cannot afford more than 15,000, IPO is the best way to go forward.
The major downside of an IPO is that the information related to the company and its financials is available only as part of the prospectus which has to be filed. And retailers would not be having the time as well as the required knowledge to understand, interpret and evaluate the same. Also, would it make time sense to spend a few days or at least a few hours for an investment that may or may not click per expectations? I do not feel so.
With IPOs, there is a 50-50% chance of it being a success on the expected lines.
My experience has not been very encouraging as I have rarely been one of the allottees of the IPOs and when I did get allotment for ICICI PRU LIFE, this is what happened --
Listing Day Trading Information
.
IPO Price
Open
Low
High
Last Trade
Volume
BSE
₹334.00
₹329.00
₹295.50
₹333.90
₹297.65
12,720,399
NSE
₹334.00
₹330.00
₹295.15
₹333.90
₹297.55
89,058,658
The IPO base price was 334 and listed at 330 and closed at 297 - a fall of 11 % on a listing day. The day happened to be a big news day when around mid-morning, the news of the surgical strike was made public and the markets had tanked.
The outcome was that the morning excitement of witnessing a listing gain faded with the gloom of a sharply discounted closing price. I ended up holding it for quite some time and made the typical mistake of exiting just above my cost. From the chart, it is very clear what followed thereafter was a steady rise and I would have been better off had I been an investor than a trader.
Then What Should I do?
Over the last few years, I have become somewhat wiser in dealing with lottery allotments as and when I get. The last was with Nazara Tech. I applied only because of RJ backing and hoped that it would get listed at a good premium.
I was lucky this time and got an allotment . When the day had come, I had already decided that if the listing is at a good premium, I will take my capital out and let the shares representing the profits made remain in my holdings for as long as I can.
So when it got listed at a super-premium and then made a high of 2024, I decided to exit around 1950 but by the time I could place the order and got filled, I got the exit price as 1920. A gain of = 65% just for parking my funds for about 2 weeks! That is certainly not bad. My capital was made free on the day of the listing and which I use as and when I feel to use it for the next IPO - it is now going to be Zomato.
So in this case, my 65% gain would be treated as my business income as I am a full-time trader and if I am able to hold on to my profit based holdings in Nazara for another 260+ days, then I would be eligible to claim any gains out of if as a long term capital gain. As of 09-07-12, the lowest price was 1432 - a good 272 away from my cost price, and assuming I exit at 1432 in the future, I would have earned another 23% gain over the 65% gain which I am holding in the form of Nazara shares.
This is how I propose to manage other IPOs . So my next try would be for Zomato. A lot is being said about it - good/bad. I am going to ignore both the views and apply and see if I get an allotment and if I get allotted, I will have to think about what to do when it gets listed and at what price. Why worry about something that is nowhere in sight?
I hope the above helps you get an idea about how you can make a beginning in the world of “Investing” in the simplest possible manner.
I would love to read your views and experience about IPOs.
Thank you for your time and Happy Investing!
Umesh
P.S. Disclaimer - The views expressed here are purely for educational and informational purposes only and not a recommendation or advice in any manner. I am not a SEBI regd., so please consult your financial advisor or be your own decision-maker as you may deem fit.
IPO
Heranba Industries Ltd - VCP & Base formation from IPO lowsHeranba Industries Ltd had formed good base from IPO lows.
VCP / C&H pattern indicates good accumulation by institutional players, & weak hands moving out of stock.
Had earlier formed a low cheat entry near 740 levels.
Stock is near Pivot point levels of 823 levels. Good move expected on close ab 823 levels on weekly basis.
Stock can be a potential Multibagger from current levels.
Long On BECTORFOODNSE:BECTORFOOD
Why long?
1. It is following the General IPO pattern and also below trend reversal patterns giving extra support for going long.
2. Invert HS pattern
3. Morning star pattern formation
4. Good RR
Note: : This is only for educational purposes and do your analysis before investing.
STOVEKRAFTSwing TrAdE options:
After Box Break-Out now forming Descending Triangle Pattern, Depends on the break-Out stock moves further.
Current Price- 595
P/E- 23.8 (less among competitors)
Short time target: 650, 690
Med Time target: 730(Pole Extension)
Pros:
Company has reduced debt.
Company has delivered good profit growth of 30.97% CAGR over last 5 years
Debtor days have improved from 47.73 to 36.00 days.
Note:
Its revenue contribution was Kitchen Appliances (88%) and Home Appliances (12%) in FY20. The improved product mix resulted in profit expansion.
Happy Trading
Abd
NURECA | IPO Details ....Started @ 15 / FEB /2021 ( Today) 🎯NURECA IPO REVIEW-
Introduction to NURECA-
-Incorporated on 2nd November 2016 @Delhi.
-B2C Home healthcare and wellness product company.
-95% Revenue online.
-1 manufacturing unit-@Chandigarh.
-3 Brands.
What does the company do-
-company enables people with tools to effectively monitor chronic illness and upgrade their lifestyles.
-company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability, and innovative designs.
-company tries to provides the home health care sector with innovation.
-Nureca company is the first digital company wherein they sell the products through online channel partners such as e-commerce players, distributors, and retailers.
The following brands are currently used by the Company-
-Dr. Trust: they provide the users to effectively monitor chronic illness and try to upgrade their lifestyle.
-Dr. Physio: This brand provides electric massagers, wheelchairs, and walkers.
-Trump: This brand provides the Mother and Child Care category.
NURECA PRODUCTS-
-Chronic Device Products- products such as blood pressure monitors, pulse oximeters, thermometers, nebulizers, self-monitoring glucose devices, humidifier ands teamers.
-Orthopedic Products-such as wheelchairs, walkers and physiotherapy electric massagers.
-Mother and Child Products- such as breast pumps, bottle sterilizers, bottle warmers, car seats and baby carrycots.
-Nutrition Supplements- such as fish oil, multivitamins, probiotics, biotin, apple cider and vinegar.
-Lifestyle Products- such as smart scales, aroma diffusers and fitness trackers.
NURECA'S Strength-
-Most of the products of NURECA is outsourced.
-Due to this their cost of production is low comparatively.
-Asset light model.
-It increased the production capacity.
-Bring product on semi-knocked down condition.
-V-shaped recovery.
-Nureca has a strong portfolio of products and a consistent focus on quality and innovation.
Financial Analysis-
-It has grown at a CAGR of 122.49%. As for the total assets, that has grown at a CAGR of 117.12%.
-The profits after tax, the growth rate is more moderate.
-Over the past three years, the net income has grown at a CAGR of 41.42%.
-The negative net cash flow from operating activities has grown at a CAGR of above 780%.
-the increasing burden of long-term debt. From Rs. 43 lakhs in 2019 to Rs. 9.77 crores in 2020 is an increase of over 2000%.
-If this debt burden continues to increase at this rate, it will create pressure on Nureca’s balance sheet.
-It was valued at Rs. 20,757 crores in 2019. By 2025, this market is expected to grow to Rs. 38,920.70 crores.
-It has grown from $24 billion in 2017 to $84 billion in 2021.
-In India especially, at least 33% of the population resorts to online shopping as opposed to conventional shopping outlets.
-Nutritional products, Rs. 17,840 crores in 2019 and it is expected to grow to Rs. 33,368 crores in 2025.
-Coming to the market for orthopedic products, in 2019, it was sized at Rs. 682.80 crores. This is expected to grow to Rs. 1,162.90 crores by 2025. The predicted CAGR, in this case, is 9.2%. The graph below shows the growing market
size over the years.
-The demand for chronic disease products is, of course, fairly inelastic in nature.
-Owing to the steadily increasing wave of chronic diseases, this demand is expected to rise in the future.
-By 2026, 12.5% of the population is expected to be geriatric in nature i.e. they will be above the age of 60. This means the demand for health-care products will only increase.
Business model-
-Nureca is a B2C company engaged in the business of home healthcare and wellness products,
-it offers quality, durability, functionality, usability and innovative designs.
-Voltas enables their customers with tools to help them monitor chronic illness and other diseases, to upgrade their lifestyle.
Risk-
-it faces stiff competition from organized and unorganized players, which leads to pricing pressure.
-it reduced margins and lower profitability.
-Home-health products are considered consumer-grade, due to concerns regarding the accuracy measures of products.
-The company does not enter into long-term contracts for the manufacturing of its products and any manufacturing-related disruption could seriously impact its business
-The company also depends heavily on its channel partners such as third-party e-commerce players, distributors, and retailers. Any failure to manage the distribution network efficiently will adversely affect its performance.
IPO details-
IPO Date February 15, 2021 to February 17, 2021
Issue Type Book Built Issue IPO
Issue Size Rs.100 Crore
Fresh Issue Rs.100 Crore
Face Value Rs.10 per equity share
IPO Price Rs.396 to Rs.400 per equity share
Market Lot 35 shares
MinOQ 35 shares
Listing At BSE, NSE
Promoter's holding-
-Saurabh Goyal 46.67%
-Payal Goyal 46.67%
Object of the issue-
-To meet the working capital requirements of the business.
-To meet the general corporate purpose.
🙏FOLLOW for more !
👍LIKE if think is useful !
✍COMMENT Below your view !
NIFTY takes support at 11250! Still in bear region.Nifty - Technical Analysis:
-Nifty was up 21.10 points or 0.19% at 11,355.
-It gapped down today and dropped to 11250 but bounced back from the support and closed postive.
-Nifty forms a doji again on daily chart indicating indecision in markets. Swing traders are advised to take their profits and wait for further levels before taking positions.
Market - Driving Factors:
-About 1212 shares have advanced, 1461 shares declined, and 187 shares are unchanged.
-Bharti Infratel, HDFC Life, Dr Reddy’s Labs, HUL and ITC were among major gainers on the Nifty, while losers were M&M, UPL, GAIL, Bajaj Finance and NTPC.
-Among sectors, FMCG and IT indices ended in the green, while selling witnessed in the auto, bank, energy and infra names.
-On day one of bidding, Happiest Minds Technologies' initial public offering is seeing a good response from retail investors so far. Expect listing gains of around 10-15%
Nifty - Outlook for Tuesday, 8th September:
NIFTY bounced from 11250 indicating a buying pressure at the support, We can expect a sideways movement before a trend is formed. On a day when markets remained flat and range bound for most part of the day we witnessed smart buying across select stocks in the broader market in diverse sectors like MNC Pharma, Chemicals & Speciality Chemicals indicating opportunities in certain spaces but people are advised to book their profits and wait for further levels.